SynBiotic WKN: A3E5A5 ISIN: DE000A3E5A59 Kürzel: SBX Forum: Aktien Thema: Hauptdiskussion
Class Action Filed Against Symbotic Inc. (SYM) - February 3, 2025 Deadline to Join - Contact Levi & Korsinsky Levi & Korsinsky, LLP (PRNewsfoto/Levi & Korsinsky, LLP) NEWS PROVIDED BY Levi & Korsinsky, LLP Dec 17, 2024, 05:45 ET NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Symbotic Inc. ("Symbotic" or the "Company") (NASDAQ: SYM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Symbotic investors who were adversely affected by alleged securities fraud between February 8, 2024 and November 26, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=116813&wire=4 SYM investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Symbotic improperly accelerated revenue recognition in its 2024 financial statements; and (2) as a result, defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. WHAT'S NEXT? If you suffered a loss in Symbotic during the relevant time frame, you have until February 3, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 17th Floor New York, NY 10004 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com SOURCE Levi & Korsinsky, LLP
|
Thema | ||
---|---|---|---|
1 | Aethlon Medical, Inc. | +33,83 % | |
2 | ATOS Hauptdiskussion | +4,76 % | |
3 | BTC/USD Hauptdiskussion | -2,04 % | |
4 | VALNEVA SE Hauptdiskussion | +0,20 % | |
5 | Nio für normale Kommunikation | +0,06 % | |
6 | VW Hauptdiskussion | -0,23 % | |
7 | MODERNA INC. DL-,0001 Hauptdiskussion | +0,16 % | |
8 | BASF Hauptdiskussion | +0,05 % | |
9 | Microvast | -0,68 % | |
10 | Trading- und Aktien-Chat | Alle Diskussionen |
|
Thema | ||
---|---|---|---|
1 | Aethlon Medical, Inc. | +33,83 % | |
2 | ATOS Hauptdiskussion | +4,76 % | |
3 | VALNEVA SE Hauptdiskussion | +0,20 % | |
4 | Nio für normale Kommunikation | +0,06 % | |
5 | VW Hauptdiskussion | -0,23 % | |
6 | MODERNA INC. DL-,0001 Hauptdiskussion | +0,16 % | |
7 | BASF Hauptdiskussion | +0,05 % | |
8 | Microvast | -0,68 % | |
9 | Marathon Digital Holdings | ±0,00 % | |
10 | News - InnoCan Pharma Aktie | ±0,00 % | Alle Diskussionen |